The American Pharma Machine is about to get a serious turbocharge! 🚀

A fascinating look into the strategic shift within US drug regulation. The pressure is mounting on the FDA to streamline the initial stages of drug development—specifically Phase 1 studies and IND approvals—as global competitors, particularly China, gain significant ground. What does this mean for research sites on the ground? Experts suggest this move is designed to create an easier gateway for sponsors, potentially leading to a significant uptick in clinical trial activity across the board. This is a major pivot in global medical research competition.
#FDA #Speed #Drug #Development #Clinical #Trials #Pharma #Race #IND #Approval #Biotech #News #China #Competition

Видео The American Pharma Machine is about to get a serious turbocharge! 🚀 канала Dan Sfera